DropGenie logo — Accelerating the pace of discovery

DropGenie

Accelerating the pace of discovery

Founded 2018 United States Boston, United States 8 employees Non Equity Assistance Biotechnology

General Information

Company Name DropGenie
Founded Year 2018
Location United States Boston, United States
Employees 8
Industries Biotechnology
Funding Stage Non Equity Assistance
Social

BounceWatch is an independent company data service, not affiliated with DropGenie. To contact DropGenie, visit drop-genie.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About DropGenie

DropGenie aims to accelerate the pace of discovery in the biotechnology industry with its innovative solutions. The company, founded in 2018 in the United States, focuses on supercharging automation and reducing the time to answer through miniaturization and parallelization. Their first product offering, an automation-compatible microfluidics chip, enables non-viral transfection in precious cells. This breakthrough technology opens the door to whole genome arrayed CRISPR screening at single donor resolution. The company recently received a non-equity assistance investment from OneRise at 28th February 2023. DropGenie's exciting and pioneering endeavors in the biotechnology sector are attracting attention and investment interest, positioning it as a promising venture for potential investors looking to tap into the advancements within the industry.

Taxonomy: microfluidics, transfection, CRISPR, screening, genomics

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Undisclosed 1
OneRise
28 Feb 2023
Non Equity Assistance Undisclosed 1
BioTools Innovator
06 Jul 2022
Seed Round Undisclosed 2
SOSV, TechU Ventures
01 Oct 2021
Convertible Note Undisclosed 2
SOSV, RebelBio
06 May 2020
Seed Round Undisclosed 3
Real Ventures, SOSV +1
29 Apr 2019
Seed Round Undisclosed 1
Bolt
28 Nov 2018
Seed Round Undisclosed 1
RebelBio
27 Jul 2018

DropGenie Alternatives & Competitors

View All Alternatives
DropGenie vs

High-content CRISPR screening in primary human cells for unbiased target discovery and AI-driven fou...

24 employees
Biotechnology
DropGenie vs

CRISPR

Series E
9 employees
Biopharma, Biotechnology
DropGenie vs
Namocell
Namocell United States

The Fastest Way to Single Cells

Series A
8 employees
Biotechnology, Life Sciences

FAQ About DropGenie

Accelerating the pace of discovery
DropGenie was founded in 2018.
DropGenie is headquartered in Boston, United States.
DropGenie operates in Biotechnology. Its work centres on microfluidics, transfection, CRISPR and screening.
DropGenie has approximately 8 employees.
DropGenie has completed 7 funding rounds. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to DropGenie include Myllia Biotechnology, G+FLAS Life Sciences, Inc., Namocell, Velabs Therapeutics, Indee Labs. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
DropGenie and Myllia Biotechnology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for DropGenie, https://bouncewatch.com/company/dropgenie, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes